Review of sociodemographic risk factors for presentation with advanced non-melanoma skin cancer

References

• Gordon R. Skin cancer: an overview of epidemiology and risk factors. Semin Oncol Nurs. 2013;29(3):160–169. doi:10.1016/j.soncn.2013.06.002.
   PubMedGoogle Scholar
• Aggarwal P, Knabel P, Fleischer AB. United States burden of melanoma and non-melanoma skin cancer from 1990 to 2019. J Am Acad Dermatol. 2021;85(2):388–395. doi:10.1016/j.jaad.2021.03.109.
   PubMed Web of Science ®Google Scholar
• Kansara S, Bell D, Weber R. Surgical management of non melanoma skin cancer of the head and neck. Oral Oncol. 2020;100:104485. doi:10.1016/j.oraloncology.2019.104485.
   PubMed Web of Science ®Google Scholar
• Veness MJ. Defining patients with high-risk cutaneous squamous cell carcinoma. Australas J Dermatol. 2006;47(1):28–33. doi:10.1111/j.1440-0960.2006.00218.x.
   PubMed Web of Science ®Google Scholar
• Research Program S. National cancer institute. SEER*Explorer: an interactive website for SEER cancer statistics [Internet]. https://seer.cancer.gov/explorer/index.html. Accessed January 23, 2022.
   Google Scholar
• Kim RH, Armstrong AW. Nonmelanoma skin cancer. Dermatol Clin. 2012;30(1):125–139, ix. doi:10.1016/j.det.2011.08.008.
   PubMed Web of Science ®Google Scholar
• Kamath SD, Kircher SM, Benson AB. Comparison of cancer burden and nonprofit organization funding reveals disparities in funding across cancer types. J Natl Compr Canc Netw. 2019;17(7):849–854. doi:10.6004/jnccn.2018.7280.
   PubMed Web of Science ®Google Scholar
• Steinbauer J, Koller M, Kohl E, Karrer S, Landthaler M, Szeimies RM. Quality of life in health care of non-melanoma skin cancer - results of a pilot study. J Dtsch Dermatol Ges. 2011;9(2):129–135. doi:10.1111/j.1610-0387.2010.07547.x.
   PubMed Web of Science ®Google Scholar
• Sahl WJ. Basal cell carcinoma: influence of tumor size on mortality and morbidity. Int J Dermatol. 1995;34(5):319–321. doi:10.1111/j.1365-4362.1995.tb03610.x.
   PubMed Web of Science ®Google Scholar
• Gerring RC, Ott CT, Curry JM, Sargi ZB, Wester ST. Orbital exenteration for advanced periorbital non-melanoma skin cancer: prognostic factors and survival. Eye (Lond). 2017;31(3):379–388. doi:10.1038/eye.2016.218.
   PubMed Web of Science ®Google Scholar
• Hendren S, Chin N, Fisher S, Winters P, Griggs J, Mohile S, et al. Patients’ barriers to receipt of cancer care, and factors associated with needing more assistance from a patient navigator. J Natl Med Assoc. 2011;103(8):701–710. doi:10.1016/S0027-9684(15)30409-0.
   PubMed Web of Science ®Google Scholar
• Grant SR, Walker GV, Guadagnolo BA, Koshy M, Allen PK, Mahmood U. Variation in insurance status by patient demographics and tumor site among nonelderly adult patients with cancer. Cancer. 2015;121(12):2020–2028. doi:10.1002/cncr.29120.
   PubMed Web of Science ®Google Scholar
• Parsons HM, Maguire FB, Morris CR, Parikh-Patel A, Brunson AM, Wun T, et al. Impact of insurance type and timing of medicaid enrollment on survival among adolescents and young adults with cancer. Pediatr Blood Cancer. 2020;67(9):e28498. doi:10.1002/pbc.28498.
   PubMed Web of Science ®Google Scholar
• Adler Jaffe S, Myers O, Meisner ALW, Wiggins CL, Hill DA, McDougall JA. Relationship between insurance type at diagnosis and hepatocellular carcinoma survival. Cancer Epidemiol Biomarkers Prev. 2020;29(2):300–307. doi:10.1158/1055-9965.EPI-19-0902.
   PubMed Web of Science ®Google Scholar
• Sturgeon A, Pate DA, Patel R, Snodgrass K, Tarbox M, Prabhu F, et al. Incidence of non-melanoma skin cancer in the uninsured. J Health Care Poor Underserved. 2017;28(4):1327–1332. doi:10.1353/hpu.2017.0117.
   PubMed Web of Science ®Google Scholar
• Cortez JL, Vasquez J, Wei ML. The impact of demographics, socioeconomics, and health care access on melanoma outcomes. J Am Acad Dermatol. 2021;84(6):1677–1683. doi:10.1016/j.jaad.2020.07.125.
   PubMed Web of Science ®Google Scholar
• Pukkala E, Martinsen JI, Lynge E, Gunnarsdottir HK, Sparen P, Trygvadottir L, et al. Occupation and cancer – follow-up of 15 million people in five Nordic countries. Acta Oncologica. 2009;48(5):646–790. doi:10.1080/02841860902913546.
   PubMed Web of Science ®Google Scholar
• Olds CE, Pepper JP. Health outcome studies in skin cancer surgery. Facial Plast Surg Clin North Am. 2019;27(1):163–170. doi:10.1016/j.fsc.2018.08.013.
   PubMed Web of Science ®Google Scholar
• Bittner GC, Cerci FB, Kubo EM, Tolkachjov SN. Mohs micrographic surgery: a review of indications, technique, outcomes, and considerations. An Bras Dermatol. 2021;96(3):263–277. doi:10.1016/j.abd.2020.10.004.
   PubMed Web of Science ®Google Scholar
• Amin MB, Gress DM, Vega LRM, Edge SB. AJCC Cancer Staging Manual, Eighth Edition. 8th ed. Greene F, Byrd D, Brookland R, Washington M, and Compton C, eds. Chicago, IL: American College of Surgeons; 2018
   Google Scholar
• United States Census Bureau. S1902: mean income in the past 12 months (in 2018 inflation-adjusted dollars). 2014-2018 American community survey. U.S. Census Bureau’s American Community Survey Office. https://data.census.gov/cedsci/; 2018. Accessed May 31, 2020.
   Google Scholar
• Tyers AG. Orbital exenteration for invasive skin tumours. Eye. 2006;20(10):1165–1170. doi:10.1038/sj.eye.6702380.
   PubMed Web of Science ®Google Scholar
• Armstrong BK, Kricker A, English DR. Sun exposure and skin cancer. Australas J Dermatol. 1997;38(Suppl 1):S1–6. doi:10.1111/j.1440-0960.1997.tb01000.x.
   PubMedGoogle Scholar
• Rigel DS. Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. J Am Acad Dermatol. 2008;58(5 Suppl 2):S129–132. doi:10.1016/j.jaad.2007.04.034.
   PubMed Web of Science ®Google Scholar
• Leonardi-Bee J, Ellison T, Bath-Hextall F. Smoking and the risk of nonmelanoma skin cancer: systematic review and meta-analysis. Arch Dermatol. 2012;148(8):939–946. doi:10.1001/archdermatol.2012.1374.
   PubMedGoogle Scholar
• Dusingize JC, Olsen CM, Pandeya NP, Subramanian P, Thompson BS, Neale RE, et al. Cigarette smoking and the risks of basal cell carcinoma and squamous cell carcinoma. J Invest Dermatol. 2017;137(8):1700–1708. doi:10.1016/j.jid.2017.03.027.
   PubMed Web of Science ®Google Scholar
• Freedman DM, Sigurdson A, Doody MM, Mabuchi K, Linet MS. Risk of basal cell carcinoma in relation to alcohol intake and smoking. Cancer Epidemiol Biomarkers Prev. 2003;12:1540–1543.
   PubMed Web of Science ®Google Scholar
• Yu SH, Bordeaux JS, Baron ED. The immune system and skin cancer. Adv Exp Med Biol. 2014;810:182–191. doi:10.1007/978-1-4939-0437-2_10.
   PubMedGoogle Scholar
• Gordon Spratt EA, Carucci JA. Skin cancer in immunosuppressed patients. Facial Plast Surg. 2013;29(5):402–410. doi:10.1055/s-0033-1353381.
   PubMed Web of Science ®Google Scholar
• Barnes JM, Johnson KJ, Boakye EA, Schapira L, Akinyemiju T, Park EM, et al. Early medicaid expansion and cancer mortality. Jnci. 2021;113(12):1714–1722. doi:10.1093/jnci/djab135.
   PubMedGoogle Scholar
• Vetterlein MW, Löppenberg B, Karabon P, Dalela D, Jindal T, Sood A, et al. Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer. Cancer. 2017;123(17):3241–3252. doi:10.1002/cncr.30744.
   PubMed Web of Science ®Google Scholar
• Guidry JJ, Aday LA, Zhang D, Winn RJ. Transportation as a barrier to cancer treatment. Cancer Pract. 1997;5:361–366.
   PubMedGoogle Scholar
• Xu Z, Becerra AZ, Justiniano CF, Boodry CI, Aquina CT, Swanger AA, et al. Is the distance worth it? Patients with rectal cancer traveling to high-volume centers experience improved outcomes. Dis Colon Rectum. 2017;60(12):1250–1259. doi:10.1097/DCR.0000000000000924.
   PubMed Web of Science ®Google Scholar
• Isshiki T. Outpatient treatment costs and their potential impact on cancer care. Cancer Med. 2014;3(6):1539–1543. doi:10.1002/cam4.308.
   PubMed Web of Science ®Google Scholar
• Cosway B, Douglas L, Armstrong N, Robson A. Travelling for treatment; does distance and deprivation affect travel for intensity-modulated radiotherapy in the rural setting for head and neck cancer? J Laryngol Otol. 2017;131(6):546–548. doi:10.1017/S0022215117000196.
   PubMed Web of Science ®Google Scholar
• Garstka M, Monlezun D, Kandil E. Does distance to treatment affect mortality rate for surgical oncology patients? Am Surg. 2020;86(9):1129–1134. doi:10.1177/0003134820943649.
   PubMed Web of Science ®Google Scholar
• Stitzenberg KB, Thomas NE, Dalton K, Brier SE, Ollila DW, Berwick M, et al. Distance to diagnosing provider as a measure of access for patients with melanoma. Arch Dermatol. 2007;143(8):991–998. doi:10.1001/archderm.143.8.991.
   PubMedGoogle Scholar
• Snyder BM, Mounessa JS, Fazzari M, Caravaglio JV, Kretowicz A, Braunberger T, et al. Greater distance to an academic medical center is associated with poorer melanoma prognostic factors: The University of Colorado experience. Dermatol Online J. 2017;23(11):13030/qt9qz0p2bz. doi:10.5070/D32311037246.
   PubMedGoogle Scholar
• Mannschreck DB, Li X, Okoye G. Rural melanoma patients in Maryland do not present with more advanced disease than urban patients. Dermatol Online J. 2021;27(5). doi: 10.5070/D327553607.
   PubMedGoogle Scholar
• Morgan FC, Duran J, Fraile B, Karia PS, Lin JY, Ott PA, et al. A comparison of skin cancer screening and treatment costs at a Massachusetts cancer center, 2008 versus 2013. J Am Acad Dermatol. 2018;79(5):921–928. doi:10.1016/j.jaad.2018.06.045.
   PubMed Web of Science ®Google Scholar
• Guy GP, Machlin SR, Ekwueme DU, Yabroff KR. Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011. Am J Prev Med. 2015;48(2):183–187. doi:10.1016/j.amepre.2014.08.036.
   PubMed Web of Science ®Google Scholar
• Noels E, Hollestein L, Luijkx K, Louwman M, de Uyl-de Groot C, van den Bos R, et al. Increasing costs of skin cancer due to increasing incidence and introduction of pharmaceuticals, 2007-2017. Acta Derm Venereol. 2020;100(10):adv00147. doi:10.2340/00015555-3463.
   PubMed Web of Science ®Google Scholar
• Poggi L, Kolesar JM. Vismodegib for the treatment of basal cell skin cancer. Am J Health Syst Pharm. 2013;70(12):1033–1038. doi:10.2146/ajhp120311.
   PubMed Web of Science ®Google Scholar
• Paul E, Konidaris G, Cope S, Chen CI, Keeping S, Xu Y, et al. Cost-effectiveness analysis of cemiplimab vs pembrolizumab for treatment of advanced cutaneous squamous cell carcinoma. Jmcp. 2021;27(11):1513–1525. doi:10.18553/jmcp.2021.21164.
   PubMed Web of Science ®Google Scholar
• Simon AE, Forbes LJL, Boniface D, Warburton F, Brain KE, Dessaix A, et al. An international measure of awareness and beliefs about cancer: development and testing of the ABC. BMJ Open. 2012;2(6):e001758. doi:10.1136/bmjopen-2012-001758.
   PubMed Web of Science ®Google Scholar
• United States Census Bureau. P2 - urban and rural. 2010 Census. Accessed May 30, 2020.
   Google Scholar